315 related articles for article (PubMed ID: 17242194)
1. TAL-1/SCL and its partners E47 and LMO2 up-regulate VE-cadherin expression in endothelial cells.
Deleuze V; Chalhoub E; El-Hajj R; Dohet C; Le Clech M; Couraud PO; Huber P; Mathieu D
Mol Cell Biol; 2007 Apr; 27(7):2687-97. PubMed ID: 17242194
[TBL] [Abstract][Full Text] [Related]
2. The bHLH TAL-1/SCL regulates endothelial cell migration and morphogenesis.
Lazrak M; Deleuze V; Noel D; Haouzi D; Chalhoub E; Dohet C; Robbins I; Mathieu D
J Cell Sci; 2004 Mar; 117(Pt 7):1161-71. PubMed ID: 14970264
[TBL] [Abstract][Full Text] [Related]
3. HIF-2alpha specifically activates the VE-cadherin promoter independently of hypoxia and in synergy with Ets-1 through two essential ETS-binding sites.
Le Bras A; Lionneton F; Mattot V; Lelièvre E; Caetano B; Spruyt N; Soncin F
Oncogene; 2007 Nov; 26(53):7480-9. PubMed ID: 17563748
[TBL] [Abstract][Full Text] [Related]
4. Chromatin immunoselection defines a TAL-1 target gene.
Cohen-Kaminsky S; Maouche-Chrétien L; Vitelli L; Vinit MA; Blanchard I; Yamamoto M; Peschle C; Roméo PH
EMBO J; 1998 Sep; 17(17):5151-60. PubMed ID: 9724651
[TBL] [Abstract][Full Text] [Related]
5. ETS1 lowers capillary endothelial cell density at confluence and induces the expression of VE-cadherin.
Lelièvre E; Mattot V; Huber P; Vandenbunder B; Soncin F
Oncogene; 2000 May; 19(20):2438-46. PubMed ID: 10828886
[TBL] [Abstract][Full Text] [Related]
6. Biosynthesis and expression of VE-cadherin is regulated by the PI3K/mTOR signaling pathway.
Bieri M; Oroszlan M; Zuppinger C; Mohacsi PJ
Mol Immunol; 2009 Feb; 46(5):866-72. PubMed ID: 18990449
[TBL] [Abstract][Full Text] [Related]
7. Decoding hematopoietic specificity in the helix-loop-helix domain of the transcription factor SCL/Tal-1.
Schlaeger TM; Schuh A; Flitter S; Fisher A; Mikkola H; Orkin SH; Vyas P; Porcher C
Mol Cell Biol; 2004 Sep; 24(17):7491-502. PubMed ID: 15314159
[TBL] [Abstract][Full Text] [Related]
8. Assembly of the oncogenic DNA-binding complex LMO2-Ldb1-TAL1-E12.
Ryan DP; Duncan JL; Lee C; Kuchel PW; Matthews JM
Proteins; 2008 Mar; 70(4):1461-74. PubMed ID: 17910069
[TBL] [Abstract][Full Text] [Related]
9. Src kinase phosphorylates vascular endothelial-cadherin in response to vascular endothelial growth factor: identification of tyrosine 685 as the unique target site.
Wallez Y; Cand F; Cruzalegui F; Wernstedt C; Souchelnytskyi S; Vilgrain I; Huber P
Oncogene; 2007 Feb; 26(7):1067-77. PubMed ID: 16909109
[TBL] [Abstract][Full Text] [Related]
10. VE-cadherin increases the half-life of VEGF receptor 2.
Calera MR; Venkatakrishnan A; Kazlauskas A
Exp Cell Res; 2004 Oct; 300(1):248-56. PubMed ID: 15383331
[TBL] [Abstract][Full Text] [Related]
11. Hepatocyte growth factor modulates vascular endothelial-cadherin expression in human endothelial cells.
Martin TA; Mansel R; Jiang WG
Clin Cancer Res; 2001 Mar; 7(3):734-7. PubMed ID: 11297270
[TBL] [Abstract][Full Text] [Related]
12. Cardiac ischemia activates vascular endothelial cadherin promoter in both preexisting vascular cells and bone marrow cells involved in neovascularization.
Kogata N; Arai Y; Pearson JT; Hashimoto K; Hidaka K; Koyama T; Somekawa S; Nakaoka Y; Ogawa M; Adams RH; Okada M; Mochizuki N
Circ Res; 2006 Apr; 98(7):897-904. PubMed ID: 16543497
[TBL] [Abstract][Full Text] [Related]
13. Zebrafish scl functions independently in hematopoietic and endothelial development.
Dooley KA; Davidson AJ; Zon LI
Dev Biol; 2005 Jan; 277(2):522-36. PubMed ID: 15617691
[TBL] [Abstract][Full Text] [Related]
14. Modulation of VE-cadherin and PECAM-1 mediated cell-cell adhesions by mitogen-activated protein kinases.
Wu J; Sheibani N
J Cell Biochem; 2003 Sep; 90(1):121-37. PubMed ID: 12938162
[TBL] [Abstract][Full Text] [Related]
15. Augmentation of endothelial cell monolayer permeability by hyperthermia but not tumor necrosis factor: evidence for disruption of vascular integrity via VE-cadherin down-regulation.
Friedl J; Turner E; Alexander HR
Int J Oncol; 2003 Sep; 23(3):611-6. PubMed ID: 12888895
[TBL] [Abstract][Full Text] [Related]
16. Transcription factor Erg regulates angiogenesis and endothelial apoptosis through VE-cadherin.
Birdsey GM; Dryden NH; Amsellem V; Gebhardt F; Sahnan K; Haskard DO; Dejana E; Mason JC; Randi AM
Blood; 2008 Apr; 111(7):3498-506. PubMed ID: 18195090
[TBL] [Abstract][Full Text] [Related]
17. IQGAP1 mediates VE-cadherin-based cell-cell contacts and VEGF signaling at adherence junctions linked to angiogenesis.
Yamaoka-Tojo M; Tojo T; Kim HW; Hilenski L; Patrushev NA; Zhang L; Fukai T; Ushio-Fukai M
Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):1991-7. PubMed ID: 16763158
[TBL] [Abstract][Full Text] [Related]
18. The tumour necrosis factor-alpha induced vascular permeability is associated with a reduction of VE-cadherin expression.
Hofmann S; Grasberger H; Jung P; Bidlingmaier M; Vlotides J; Janssen OE; Landgraf R
Eur J Med Res; 2002 Apr; 7(4):171-6. PubMed ID: 12010652
[TBL] [Abstract][Full Text] [Related]
19. Hydrostatic pressure influences morphology and expression of VE-cadherin of vascular endothelial cells.
Ohashi T; Sugaya Y; Sakamoto N; Sato M
J Biomech; 2007; 40(11):2399-405. PubMed ID: 17261311
[TBL] [Abstract][Full Text] [Related]
20. Angiogenesis: the VE-cadherin switch.
Wallez Y; Vilgrain I; Huber P
Trends Cardiovasc Med; 2006 Feb; 16(2):55-9. PubMed ID: 16473763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
